Is YKL-40 (CHI3-L1) a new possible biomarker prognosticator in high grade glioma?

Authors

  • A. Oslobanu
  • St. I. Florian

Keywords:

biomarkers, high grade glioma, YKL-40

Abstract

A biomarker is “a naturally occurring molecule, gene, or characteristic by which a particular pathological or physiological process, disease, etc. can be identified” and it could be used a measurable indicator for the presence or severity of disease state. YKL-40 is a secreted glycoprotein associated with extracellular matrix, a member of the mammalian chitinase-like proteins that is expressed in a several types of solid tumors. Although the implication of this biomarker in tissue remodeling processes or the role in cancer cell proliferation, invasiveness, angiogenesis, and remodeling of the extracellular matrix is going to be well recognized, the regulation and role in glioblastoma multiforme (GBM) progression remains unknown. Using the serum level of YKL-40 as a single screening test in cancer cannot be used, but in association with other tumoral biomarkers and imaging techniques can be a useful tool as a “prognosticator.” Moreover, elucidation of the YKL-40 functions could be an attractive target for antitumor therapy.

Author Biographies

  • A. Oslobanu

    Assistant Professor in Neurosurgery. University of Medicine and Pharmacy, “Iuliu Hatieganu” Cluj-Napoca. Romania

  • St. I. Florian

    Professor in Neurosurgery. University of Medicine and Pharmacy, “Iuliu Hatieganu” Cluj-Napoca. Romania

Downloads

Published

2015-09-15

Issue

Section

Articles

How to Cite

Is YKL-40 (CHI3-L1) a new possible biomarker prognosticator in high grade glioma? (2015). Romanian Neurosurgery, 29(3), 247-253. https://staging.journals.lapub.co.uk/index.php/roneurosurgery/article/view/831

Similar Articles

1-10 of 284

You may also start an advanced similarity search for this article.